...
search icon

Price related data not available

Aquestive Therapeutics Inc Analyst Forecast

Price related data not available

Aquestive Therapeutics Inc Stock Returns

Time FrameAQSTSectorS&P500
1-Week Return-0.24%1.37%1.24%
1-Month Return-1.9%-6.81%-4.59%
3-Month Return-35.97%-5%-4.14%
6-Month Return-28.42%3.17%-2.1%
1-Year Return35.86%2.38%16.07%
3-Year Return289.62%12.85%59.52%
5-Year Return-20.73%26.05%61.27%
10-Year Return-74.27%112.96%218.39%

Aquestive Therapeutics Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue50.83M47.68M50.58M57.56M44.55M[{"date":"2021-12-31","value":88.31,"profit":true},{"date":"2022-12-31","value":82.83,"profit":true},{"date":"2023-12-31","value":87.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":77.39,"profit":true}]
Cost of Revenue14.99M19.39M20.83M17.87M18.55M[{"date":"2021-12-31","value":71.96,"profit":true},{"date":"2022-12-31","value":93.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.8,"profit":true},{"date":"2025-12-31","value":89.07,"profit":true}]
Gross Profit35.84M28.29M29.75M39.69M25.99M[{"date":"2021-12-31","value":90.31,"profit":true},{"date":"2022-12-31","value":71.29,"profit":true},{"date":"2023-12-31","value":74.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":65.48,"profit":true}]
Gross Margin70.51%59.34%58.82%68.95%58.35%[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.16,"profit":true},{"date":"2023-12-31","value":83.42,"profit":true},{"date":"2024-12-31","value":97.79,"profit":true},{"date":"2025-12-31","value":82.74,"profit":true}]
Operating Expenses70.52M70.36M44.85M70.46M97.04M[{"date":"2021-12-31","value":72.67,"profit":true},{"date":"2022-12-31","value":72.51,"profit":true},{"date":"2023-12-31","value":46.22,"profit":true},{"date":"2024-12-31","value":72.61,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income(34.68M)(42.07M)(15.10M)(30.77M)(71.05M)[{"date":"2021-12-31","value":-3467900000,"profit":false},{"date":"2022-12-31","value":-4206600000,"profit":false},{"date":"2023-12-31","value":-1510200000,"profit":false},{"date":"2024-12-31","value":-3077100000,"profit":false},{"date":"2025-12-31","value":-7105100000,"profit":false}]
Total Non-Operating Income/Expense(57.90M)(24.69M)16.34M(26.76M)(25.47M)[{"date":"2021-12-31","value":-354.42,"profit":false},{"date":"2022-12-31","value":-151.13,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-163.81,"profit":false},{"date":"2025-12-31","value":-155.89,"profit":false}]
Pre-Tax Income(70.54M)(54.41M)(7.63M)(44.15M)(83.78M)[{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-762500000,"profit":false},{"date":"2024-12-31","value":-4415100000,"profit":false},{"date":"2025-12-31","value":-8378400000,"profit":false}]
Income Taxes19.50M5.79M245.00K(14.00K)-[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":29.71,"profit":true},{"date":"2023-12-31","value":1.26,"profit":true},{"date":"2024-12-31","value":-0.07,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes(90.04M)(60.20M)(7.87M)(44.14M)-[{"date":"2021-12-31","value":-9003600000,"profit":false},{"date":"2022-12-31","value":-6020200000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Income From Continuous Operations(70.54M)(54.41M)(7.87M)(44.14M)(83.78M)[{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false},{"date":"2025-12-31","value":-8378400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income(70.54M)(54.41M)(7.87M)(44.14M)(83.78M)[{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false},{"date":"2025-12-31","value":-8378400000,"profit":false}]
EPS (Diluted)(1.49)(1.14)(0.36)(0.49)(0.76)[{"date":"2021-12-31","value":-149,"profit":false},{"date":"2022-12-31","value":-114,"profit":false},{"date":"2023-12-31","value":-36,"profit":false},{"date":"2024-12-31","value":-49.07,"profit":false},{"date":"2025-12-31","value":-76.35,"profit":false}]

Aquestive Therapeutics Inc Ratios

Aquestive Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AQST
Cash Ratio 2.55
Current Ratio 3.14
Quick Ratio 3.01

Aquestive Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AQST
ROA (LTM) -33.92%
ROE (LTM) 0.00%

Aquestive Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AQST
Debt Ratio Lower is generally better. Negative is bad. 1.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.21

Aquestive Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AQST
Trailing PE NM
Forward PE NM
P/S (TTM) 11.32
P/B 0.00
Price/FCF NM
EV/R 9.60
EV/Ebitda NM

FAQs

What is Aquestive Therapeutics Inc share price today?

Aquestive Therapeutics Inc (AQST) share price today is $4.13

Can Indians buy Aquestive Therapeutics Inc shares?

Yes, Indians can buy shares of Aquestive Therapeutics Inc (AQST) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AQST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aquestive Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Aquestive Therapeutics Inc (AQST) via the Vested app. You can start investing in Aquestive Therapeutics Inc (AQST) with a minimum investment of $1.

How to invest in Aquestive Therapeutics Inc shares from India?

You can invest in shares of Aquestive Therapeutics Inc (AQST) via Vested in three simple steps:

  • Click on Sign Up or Invest in AQST stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aquestive Therapeutics Inc shares
What is Aquestive Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Aquestive Therapeutics Inc (AQST) is $7.55. The 52-week low price of Aquestive Therapeutics Inc (AQST) is $2.12.

What is Aquestive Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aquestive Therapeutics Inc (AQST) is

What is Aquestive Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aquestive Therapeutics Inc (AQST) is 0.00

What is Aquestive Therapeutics Inc dividend yield?

The dividend yield of Aquestive Therapeutics Inc (AQST) is 0.00%

What is the Market Cap of Aquestive Therapeutics Inc?

The market capitalization of Aquestive Therapeutics Inc (AQST) is $504.05M

What is Aquestive Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Aquestive Therapeutics Inc is AQST

How Can Investors Use Aquestive Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Aquestive Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Aquestive Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Aquestive Therapeutics Inc shares for Indian investors?

When investing in Aquestive Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Aquestive Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Aquestive Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Aquestive Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Aquestive Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top